Drug Development Solutions
-
Services For Advancing mRNA-LNPs From Bench To Clinic
2/27/2023
Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.
-
Where Expertise Meets Simplicity: BD PartnerPath™ Program
8/12/2021
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
-
Scientific Insights Lab Simplifying The Journey From Molecule To Market
Drug development programs should aid customers in the successful mitigation of technical and regulatory risks to ensure drug products move swiftly through the regulatory approval process and into commercialization. Get service and support to help pharmaceutical and biopharmaceutical manufacturers Simplify the Journey™ from molecule to market.
-
State-Of-The-Art Drug Product Manufacturing Capabilities
1/26/2026
Integrated development, analytical, and manufacturing capabilities streamline complex formulations and clinical supply, while flexible, advanced services keep teams moving challenging products forward.
-
Laboratory Services
3/2/2026
Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.
-
Developing Palatable, Age Appropriate Drug Products
10/15/2025
Our expertise and capabilities enable us to meet the complex technical challenges of pediatric products and provide you with a unique integrated development solution.
-
Put Your Oligo Synthesis In Good Hands
1/27/2026
Explore how smart column design supports consistent, high‑yield oligonucleotide synthesis, which formats fit development, and how optimized features help improve efficiency and safety.
-
Testing Solutions For Biosimilars
4/22/2024
Our scientists offer insights into physicochemical and structural properties, including post-translational modifications, through a range of assays.
-
Analytical, Formulation & Stability
2/17/2022
We have experience with monoclonal antibodies, antibody-drug conjugates, and many other molecule types, including highly glycosylated proteins and biosimilars.
-
Simplify Your Linker-Payload Synthesis
4/23/2024
By streamlining the synthesis pathways, see how these products can effectively diminish the requisite number of developmental and manufacturing stages essential for generating payloads.